Resminostat in advanced hepatocellular carcinoma (HCC): Overall survival subgroup analysis of prognostic factors in the SHELTER trial.
Michael Bitzer
Honoraria - 4SC A
Tom M. Ganten
No relevant relationships to disclose
Marcus A. Woerns
Consultant or Advisory Role - Bayer
Jens T. Siveke
No relevant relationships to disclose
Matthias M. Dollinger
Consultant or Advisory Role - Bayer
Research Funding - Bayer
Max E. Scheulen
No relevant relationships to disclose
Henning Wege
No relevant relationships to disclose
Edoardo G. Giannini
Consultant or Advisory Role - 4SC AG
Research Funding - 4SC AG
Umberto Cillo
No relevant relationships to disclose
Franco Trevisani
Consultant or Advisory Role - Bayer
Research Funding - Bayer
Armando Santoro
No relevant relationships to disclose
Vincenzo Montesarchio
No relevant relationships to disclose
Anna Mais
Employment or Leadership Position - 4SC AG
Bernhard Hauns
Employment or Leadership Position - 4SC AG
Julia Asche
Employment or Leadership Position - 4SC A
Thomas Herz
Employment or Leadership Position - 4SC AG
Stefano Pegoraro
Employment or Leadership Position - 4SC AG
Aldo Ammendola
Employment or Leadership Position - 4SC AG
Stefan W. Henning
Employment or Leadership Position - 4SC AG
Stock Ownership - 4SC AG
Bernd Hentsch
Employment or Leadership Position - 4SC AG
Stock Ownership - 4SC AG